ArticleJAMA network open2024

Characteristics of Patients Receiving Novel Muscular Dystrophy Drugs in Trials vs Routine Care.

Dongzhe Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.